From The Economic Times · ET Bureau · · 1m
India takes legal action against Nestle over baby food claims
Food regulator files cases over promotional violations and biotin content in infant nutrition products.
In brief
Food regulator files cases over promotional violations and biotin content in infant nutrition products. FSSAI filed three cases against Nestle India for inappropriate promotional claims on infant formula and substandard biotin levels. Originally reported by The Economic Times.
Legal action over baby formula
FSSAI filed three cases against Nestle India over violations involving NAN Excella Pro Stage 1 and Lactogen Pro 1 infant nutrition products.
Inappropriate promotional claims found
The regulator found claims about "5 HMOs" and easy-to-digest whey protein on ecommerce platforms were not appropriate for infant formula.
Regulations prohibit promotional material
Both products violated 2020 regulations that restrict promotional claims intended to increase the saleability of infant foods.
Biotin levels found substandard
A follow-up formula sample failed to meet required biotin content. A referral laboratory confirmed the water-soluble B vitamin deficiency.
Nestle says products are compliant
The company stated its products and labels were approved by FSSAI's expert committee and claims are supported by scientific literature.
“Our products are fully compliant with all applicable regulations.”
The main idea
FSSAI filed three cases against Nestle India for inappropriate promotional claims on infant formula and substandard biotin levels.
